Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?
- Sprache
-
Englisch
- Identifier
-
1227041284
Beteiligte Personen und Organisationen
Wessely, Anja
Steeb, Theresa
Leiter, Ulrike
Garbe, Claus
Berking, Carola
Heppt, Markus Vincent
Steeb, Theresa
Leiter, Ulrike
Garbe, Claus
Berking, Carola
Heppt, Markus Vincent
- DOI
-
10.3390/ijms21239300
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:55 MEZ
Beteiligte
- Wessely, Anja
- Steeb, Theresa
- Leiter, Ulrike
- Garbe, Claus
- Berking, Carola
- Heppt, Markus Vincent
Ähnliche Objekte (12)
The Role of Immune Checkpoint Blockade in Uveal Melanoma
A Systematic Review and Meta-Analysis of Interventions for Actinic Keratosis from Post-Marketing Surveillance Trials
How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance
Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
How to Assess the Efficacy of Interventions for Actinic Keratosis? A Review with a Focus on Long-Term Results
The Quality of Practice Guidelines for Melanoma: A Methodologic Appraisal with the AGREE II and AGREE-REX Instruments
The Value of Total Body Photography for the Early Detection of Melanoma: A Systematic Review
A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic Keratosis
“I Feel I’m in Best Hands with You!”: A Survey of Patient Satisfaction in a German University Skin Cancer Centre
Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies
Where do we stand with immune checkpoint blockade for advanced cutaneous squamous cell carcinoma? A systematic review and critical appraisal of the existing evidence
Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional Trial
The Role of Immune Checkpoint Blockade in Uveal Melanoma
A Systematic Review and Meta-Analysis of Interventions for Actinic Keratosis from Post-Marketing Surveillance Trials
How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance
Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
How to Assess the Efficacy of Interventions for Actinic Keratosis? A Review with a Focus on Long-Term Results
The Quality of Practice Guidelines for Melanoma: A Methodologic Appraisal with the AGREE II and AGREE-REX Instruments
The Value of Total Body Photography for the Early Detection of Melanoma: A Systematic Review
A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic Keratosis
“I Feel I’m in Best Hands with You!”: A Survey of Patient Satisfaction in a German University Skin Cancer Centre
Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies
Where do we stand with immune checkpoint blockade for advanced cutaneous squamous cell carcinoma? A systematic review and critical appraisal of the existing evidence
Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional Trial
The Role of Immune Checkpoint Blockade in Uveal Melanoma
A Systematic Review and Meta-Analysis of Interventions for Actinic Keratosis from Post-Marketing Surveillance Trials
How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance
Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
How to Assess the Efficacy of Interventions for Actinic Keratosis? A Review with a Focus on Long-Term Results
The Quality of Practice Guidelines for Melanoma: A Methodologic Appraisal with the AGREE II and AGREE-REX Instruments
The Value of Total Body Photography for the Early Detection of Melanoma: A Systematic Review
A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic Keratosis
“I Feel I’m in Best Hands with You!”: A Survey of Patient Satisfaction in a German University Skin Cancer Centre
Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies
Where do we stand with immune checkpoint blockade for advanced cutaneous squamous cell carcinoma? A systematic review and critical appraisal of the existing evidence